Quantcast

Latest Ulcerative colitis Stories

2014-07-01 23:09:21

Brought to her knees and nearly her death by ulcerative colitis, 25 year old Karin Miller was given a second chance at life thanks to a life-saving surgery. Miller used her second chance to help others with her newly launched website NewbieOstomy. (PRWEB) July 01, 2014 Ulcerative Colitis (UC) is a common inflammatory bowel disease (IBD) which affects the top layers of the colon. Left untreated, it can increase the risk of colon cancer. According to the Centers for Disease Control and...

2014-06-16 13:04:56

Wellcome Trust Sanger Institute Parasitic worm genome and biology provides a solid basis for the development of new interventions Researchers have deduced essential biological and genetic information from the genome sequence of the whipworm, an intestinal parasitic worm that infects hundreds of millions of people in developing countries. This information acts as the foundation for the development of new strategies and treatments against this debilitating parasite. The whipworm is...

2014-06-16 12:29:02

DEERFIELD, Ill., and OSAKA, Japan, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced the United States (U.S.) commercial availability of a new biologic therapy, ENTYVIO((TM) )(vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD). "We understand how a great need still exists for additional treatment options...

2014-05-28 16:27:04

ROME, May 28, 2014 /PRNewswire/ -- Sigma-Tau announces that Synacthen (R) (tetracosactide hexa-acetate salt) is now available again in most of the European countries. (Logo: http://photos.prnewswire.com/prnh/20140528/689733 ) Manufacturing challenges connected to tetracosactide over the past months caused the shortage of -Synacthen(R)- for patients throughout Europe and Sigma-Tau has devoted all its efforts in reestablishing the supply chain into these...

2014-05-26 11:13:00

UT Southwestern Medical Center A microRNA cluster believed to be important for suppressing colon cancer has been found to play a critical role in wound healing in the intestine, UT Southwestern cancer researchers have found. The findings, first discovered in mice and later reproduced in human cells, could provide a fresh avenue for investigating chronic digestive diseases and for potentially repairing damage in these and other disease or injury settings. "We identified a novel role...

2014-05-21 23:08:04

ReportsnReports.com adds “Crohn’s Disease Drug Market and Pipeline Analysis” report to its research store. Dallas, Texas (PRWEB) May 21, 2014 Under the umbrella of inflammatory bowel diseases, Crohn’s disease and ulcerative colitis are two most common disorders. Though both these disorders have similar symptoms, the difference arises in the areas affected in the gastrointestinal tract (GI tract). The Crohn’s disease in most cases affects the end of the small bowel (the ileum)...

2014-05-20 20:22:08

DEERFIELD, Ill. and OSAKA, Japan, May 20, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio((TM)) (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD). ( ) "Entyvio is a new option that...

2014-05-19 12:31:13

LONDON, May 19, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Needhttp://www.reportbuyer.com/pharma_healthcare/treatments/gastrointestinal_therapeutics_asia_pacific_markets_2019_strong_potential_pipeline_biologics_account_high_regional_unmet_need.htmlGastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong...

2014-05-15 16:27:54

NEW YORK, May, 15, 2014 /PRNewswire-USNewswire/ -- In an effort to increase their long-standing commitment of improving the lives of those with inflammatory bowel disease (IBD), the Crohn's & Colitis Foundation of America (CCFA) will host the first U.S. IBD2020 meeting from May 16(th)- May 18(th) in New Orleans, LA. http://photos.prnewswire.com/prnvar/20140515/88144 "IBD2020 USA is a critical meeting of some of the brightest minds who are thinking about both IBD and Quality of...

2014-05-13 00:21:38

- This Is First Study to Demonstrate Clinical Benefit of Oral alpha 4 Integrin Antagonist in Patient with Inflammatory Bowel Disease - TOKYO, May 13, 2014 /PRNewswire/ -- Ajinomoto Pharmaceuticals Co., Ltd. (President, Takashi Nagamachi; Headquarters, Tokyo, Japan) announced on May 13 that the Phase 2a results of an oral alpha 4 integrin antagonist, AJM300, in patients with ulcerative colitis were presented in the Joint Presidential Plenary Session at Digestive Disease Week (DDW)...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related